US 7388017
Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease
granted A61KA61K38/00A61P
Quick answer
US patent 7388017 (Inhibitors of serine proteases, particularly hepatitis C virus NS3 protease) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vertex Pharmaceuticals Incorporated
- Grant date
- Tue Jun 17 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 12 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 41
- CPC classes
- A61K, A61K38/00, A61P, A61P1/16, A61P31/12